M. Wilkie

Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer

J. Coxhead, R. Steele, Gillian Smith, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk

J. Barrett, D. Forman, R. Steele, 2010, Pharmacogenetics and genomics.

Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy?

Gillian Smith, M. Wilkie, P. Beattie, 2007, Journal of the American Academy of Dermatology.

A splice site polymorphism in the G-protein &bgr; subunit influences antidepressant efficacy in depression

D. Blackwood, K. Matthews, Gillian Smith, 2007, Pharmacogenetics and genomics.

A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.

J. Barrett, D. Forman, Gillian Smith, 2002, Carcinogenesis.

Methylene Tetrahydrofolate Reductase Genotype Modifies the Chemopreventive Effect of Folate in Colorectal Adenoma, but not Colorectal Cancer

J. Barrett, D. Forman, T. Key, 2008, Cancer Epidemiology Biomarkers & Prevention.

Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen–ultraviolet A photochemotherapy

M. Wilkie, C. Wolf, S. Ibbotson, 2007, The British journal of dermatology.

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

D. Blackwood, K. Matthews, Gillian Smith, 2009, The Pharmacogenomics Journal.

Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1

R. Finn, Gillian Smith, M. Wilkie, 2005, Pharmacogenetics and genomics.